Fact checked byMark Leiser

Read more

December 28, 2022
1 min read
Save

Roswell Park names chair of cancer genetics and genomics

Fact checked byMark Leiser
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Joyce Ohm, PhD, has been named chair of cancer genetics and genomics at Roswell Park Comprehensive Cancer Center.

Ohm — an epigenetics researcher who joined the institution as associate professor of oncology in 2016 — also will serve as John and Santa Palisano endowed chair of cancer genetics.

Graphic with quote from Renier Brentjens, MD, PhD

Ohm — who has more than 25 years of experience in cancer research — has made important contributions in multiple areas, including tumor-associated immune suppression and identification of genetic mutations that drive response to therapy.

Joyce Ohm, PhD
Joyce Ohm

Her other interest areas include translocation-associated sarcomas, environmental exposures and tumor initiation, stem cell biology and molecular signatures for lung cancer.

“As we look to position Roswell Park as a global leader in combining epigenetic therapy and immunotherapies, I can think of no better person to help guide our team than Dr. Ohm,” Renier Brentjens, MD, PhD, deputy director and chair of the department of medicine at Roswell Park, said in a press release. “Her rigor and determination are palpable in a field that has tremendous potential and impact for [patients with cancer] and loved ones. We are excited to see where she takes it next.”